Lori A Devlin, Janis L Breeze, Norma Terrin, Enrique Gomez Pomar, Henrietta Bada, Loretta P Finnegan, Kevin E O'Grady, Hendrée E Jones, Barry Lester, Jonathan M Davis
Importance: Observer-rated scales, such as the Finnegan Neonatal Abstinence Scoring Tool (FNAST), are used to quantify the severity of neonatal abstinence syndrome (NAS) and guide pharmacologic therapy. The FNAST, a comprehensive 21-item assessment tool, was developed for research and subsequently integrated into clinical practice; a simpler tool, designed to account for clinically meaningful outcomes, is urgently needed to standardize assessment. Objectives: To identify FNAST items independently associated with the decision to use pharmacologic therapy and to simplify the FNAST while minimizing loss of information for the treatment decision...
April 1, 2020: JAMA Network Open